Shiva K. Mukkamalla
Expertise in
3
conditions

Dr. Shiva K. Mukkamalla

Hematology Oncology
81 Hillcrest Drive, Suite 2400, 
Punxsutawney, PA 
Accepting New Patients
17 Years of Experience
Referral may be required
Before you request
Expertise in
3
conditions
81 Hillcrest Drive, Suite 2400, 
Punxsutawney, PA 

Overview

Shiva Kumar R. Mukkamalla, MD, MPH, specializes in hematology oncology and is board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center - Punxsutawney Area Hospital and IRMC Cancer Center in Partnership with UPMC Hillman Cancer Center. Dr. Mukkamalla completed his medical degree at Osmania Medical College, residency at Queens Hospital Center, and fellowship at Roger Williams Medical Center.

Dr. Mukkamalla is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Lynch Syndrome, Follicular Lymphoma, Breast Cancer, and Idiopathic Neutropenia.

Dr. Mukkamalla is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 13 peer reviewed articles. Dr. Mukkamalla is currently accepting new patients.

Graduate Year

2009

Specialties

Hematology Oncology

Board Certifications

American Board Of Internal Medicine
American Board Of Internal Medicine
American Board Of Internal Medicine

Fellowships

Roger Williams Medical Center

Hospital Affiliations

Punxsutawney Area Hospital
Penn Highlands Dubois
Indiana Regional Medical Center
Excela Health Latrobe Hospital
Conemaugh Miners Medical Center

Languages Spoken

English
Arabic
Cantonese
Hindi
Telugu
Urdu

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

UPMC Hillman Cancer Center, Punxsutawney Area Hospital
81 Hillcrest Drive, Suite 2400, Punxsutawney, PA 15767
Other Locations
IRMC Cancer Center, in partnership with UPMC Hillman Cancer Center
850 Hospital Road, Suite 1300, Indiana, PA 15701

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Total Publications

Long Durable Response With Trastuzumab Deruxtecan Monotherapy in a Triple-Negative Metastatic Breast Cancer Patient With Human Epidermal Growth Factor Receptor 2 Mutation: A Long-Term Follow-Up and Literature Review.
Long Durable Response With Trastuzumab Deruxtecan Monotherapy in a Triple-Negative Metastatic Breast Cancer Patient With Human Epidermal Growth Factor Receptor 2 Mutation: A Long-Term Follow-Up and Literature Review.
Journal: Journal of medical cases
Published: April 29, 2025
Similar Doctors
Expertise in
41
conditions
Dr. Melissa A. Burgess
Hematology Oncology
Expertise in
41
conditions
Dr. Melissa A. Burgess
Hematology Oncology
Referral may be required
Before you request

UPMC Hillman Cancer Center

5115 Centre Avenue, Hillman Cancer Center, 
Pittsburgh, PA 
 (61.5 miles away)
412-623-4759
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is highly rated in 41 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery. Dr. Burgess is board certified in American Board Of Internal Medicine. Dr. Burgess is currently accepting new patients.

Expertise in
13
conditions
Dr. Liza C. Villaruz
Hematology Oncology
Expertise in
13
conditions
Dr. Liza C. Villaruz
Hematology Oncology
Referral may be required
Before you request

UPMC Hillman Cancer Center

5115 Centre Avenue, Hillman Cancer Center, 
Pittsburgh, PA 
 (61.5 miles away)
412-530-6683
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Villaruz is board certified in American Board Of Internal Medicine. Dr. Villaruz is currently accepting new patients.

Expertise in
11
conditions
Dr. Diwakar D. Davar
Hematology Oncology
Expertise in
11
conditions
Dr. Diwakar D. Davar
Hematology Oncology
Referral may be required
Before you request

UPMC Hillman Cancer Center

5115 Centre Avenue, Hillman Cancer Center, 
Pittsburgh, PA 
 (61.5 miles away)
412-438-2358
Languages Spoken:
English, Tamil
See accepted insurances
Accepting New Patients
Offers Telehealth

Diwakar Davar, MBBS, M.Sc is an assistant professor of medicine and a medical oncologist/hematologist. He specializes in the management of advanced melanoma and the development of early phase studies to test novel immunotherapeutic approaches to treat advanced cancers.;. Dr. Davar is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Uveal Melanoma, and Gamma Knife Radiosurgery. Dr. Davar is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Davar is currently accepting new patients.

Frequently Asked Questions about Dr. Shiva K. Mukkamalla

How do I make an appointment with Dr. Shiva K. Mukkamalla?

You can book an appointment with Dr. Shiva K. Mukkamalla by calling their office at 814-938-5212. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Shiva K. Mukkamalla a top-rated expert for Lynch Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shiva K. Mukkamalla is classified as an Advanced expert for Lynch Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Shiva K. Mukkamalla specialize in?

While Dr. Shiva K. Mukkamalla is a Hematology Oncology, they have specific expertise in Lynch Syndrome, Follicular Lymphoma, and Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Shiva K. Mukkamalla participate in research or clinical trials?

Yes. Dr. Shiva K. Mukkamalla has published 13 articles and abstracts on conditions like Lynch Syndrome. You can view a list of Dr. Shiva K. Mukkamalla's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Shiva K. Mukkamalla accept my insurance?

Dr. Shiva K. Mukkamalla accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 814-938-5212 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mukkamalla's expertise for a condition
ConditionClose
      View All 110 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile